EMERFETAMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Investigational

Investigational

Approval Year

Name

Type

Language

IMMUNOGLOBULIN, ANTI-(HUMAN SIALIC ACID-BINDING IG-LIKE LECTIN 3) (HUMAN MONOCLONAL 1837MNGSSMABC SINGLE-CHAIN VARIABLE FRAGMENT VH1-(GGGGS)3-VL1) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD3 ANTIGEN .EPSI

Preferred Name

English

EMERFETAMAB

Official Name

English

EMERFETAMAB [USAN]

Common Name

English

IMMUNOGLOBULIN SCFV-SCFV-SCFC, ANTI-(HOMO SAPIENS CD33 (SIALIC ACID BINDING IG-LIKE LECTIN 3, SIGLEC3, SIGLEC-3, GP67, P67)) AND ANTI-(HOMO SAPIENS CD3E (CD3 EPSILON, LEU-4)), MONOCLONAL ANTIBODY SINGLE CHAIN (SCFV)2-SCFC, BISPECIFIC; IG SCFV-SCFV-SCFC S

Common Name

English

AMG-673

Code

English

emerfetamab [INN]

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

655818

Created by admin on Tue Apr 01 21:58:02 GMT 2025 , Edited by admin on Tue Apr 01 21:58:02 GMT 2025

Code System Code Type Description

CAS

2250261-27-7

Created by admin on Tue Apr 01 21:58:02 GMT 2025 , Edited by admin on Tue Apr 01 21:58:02 GMT 2025

PRIMARY

FDA UNII

HOG226RYH1

Created by admin on Tue Apr 01 21:58:02 GMT 2025 , Edited by admin on Tue Apr 01 21:58:02 GMT 2025

PRIMARY

USAN

JK-129

Created by admin on Tue Apr 01 21:58:02 GMT 2025 , Edited by admin on Tue Apr 01 21:58:02 GMT 2025

PRIMARY

CAS

2641417-67-4

Created by admin on Tue Apr 01 21:58:02 GMT 2025 , Edited by admin on Tue Apr 01 21:58:02 GMT 2025

NO STRUCTURE GIVEN

INN

11239

Created by admin on Tue Apr 01 21:58:02 GMT 2025 , Edited by admin on Tue Apr 01 21:58:02 GMT 2025

PRIMARY

NCI_THESAURUS

C175778

Created by admin on Tue Apr 01 21:58:02 GMT 2025 , Edited by admin on Tue Apr 01 21:58:02 GMT 2025

PRIMARY

SMS_ID

300000035040

Created by admin on Tue Apr 01 21:58:02 GMT 2025 , Edited by admin on Tue Apr 01 21:58:02 GMT 2025

PRIMARY

ACTIVE MOIETY


					HOG226RYH1